Glucotrack (GCTK) Notes Payables (2010 - 2025)
Glucotrack (GCTK) reported Notes Payables of $3.2 million for Q4 2025, up 63540.0% year-on-year from N/an in Q4 2024, and up 4.98% quarter-over-quarter from $3.0 million in Q3 2025.
Glucotrack (GCTK) has 6 years of Notes Payables data on file, last reported at $3.2 million in Q4 2025.
- For the quarter ending Q4 2025, Notes Payables rose 63540.0% year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (up 63540.0% YoY), and the FY2025 full-year result was $3.2 million, up 63540.0% from the prior year.
- Notes Payables for Q4 2025 stood at $3.2 million, up from $3.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $3.2 million in Q4 2025 and bottomed at $5000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2014 | 23,838.00 |
| Dec 31, 2012 | 37,427.00 |
| Sep 30, 2012 | 50,980.00 |
| Mar 31, 2011 | 29,890.00 |
| Dec 31, 2010 | 18,843.00 |